News
Olumiant Approved for COVID-19 Treatment in Hospitalized Adults
The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen